Diagnostic ultrasound ( PDFDrive )

Index I-15
Color Doppler ultrasound (Continued)
green-tag feature in, 932–933
interpretation of, 28, 28f–29f
interventional sonography, pediatric and, 1945
limitations of, 25b
for neonatal/infant brain, 1573–1574
operating modes in, 30–31
for pancreatic carcinoma, 241, 241b, 241f–243f,
241t
for percutaneous needle biopsies, 599
in placenta accreta diagnosis, 1471
in placenta blood low assessment, 1468–1469
in pleural luid imaging, 1709, 1710f
power compared to conventional, 25, 26f
PRF in, 28, 29f, 30–31
process of, 24, 26f
prostate cancer and, 404f, 406
slow-low sensitivity settings on, 939
for testicular torsion, pediatric, 1895–1899,
1896b
for testicular tumors, pediatric, 1901–1902
in ureteral calculi detection, 337, 339f
for ureteral jets evaluation, 1781f
weighted mean frequency in, 28
Color gain, in renal artery duplex Doppler
sonography, 449
Color streaking, breast cysts with, 775, 776f
Colpocephaly, 1202f
in Chiari II malformation, 1526, 1527f
in corpus callosum agenesis, 1528, 1530f
Column of Bertin, in kidney development, 1781,
1783, 1784f
Coma, brain death diferentiated from, 1618–1620,
1620f
Comet-tail artifacts, 202, 695
in benign and malignant thyroid nodule
diferentiation, 712–713
in degenerative cysts of thyroid, 1646, 1647f
Common bile duct
anastomosis of, for liver transplantation, 625
dilation of, cylindrical or saccular, pediatric,
1735, 1736f
diverticula of, 1735
stones in, 173–174, 173f
acute pancreatitis and, 221
liver transplantation complications with, 629,
632f
Common femoral vein
as landmark for femoral hernias, 482, 485f
normal anatomy of, 500, 981f
Complete molar pregnancy, 1078, 1079f
Complete subclavian steal, 952–953, 953b, 953f
Complete TGA, 1289, 1289f
Complicated cysts, of breast, 775–780, 776f
Compression
of amplitudes, 9
ballottement and, 768
for breast sonography, 768, 772, 773f
of femoral vein, normal, 982f
maneuvers, for dynamic ultrasound of hernia,
474, 475f
for parathyroid gland adenomas detection,
739
sot tissue ganglia causing, 865
in sound wave, 2, 2f
Compression sonography, 258–260, 261f
Computed tomography (CT)
in abdominal aortic aneurysm
rupture evaluation and, 438, 439f
for screening and surveillance, 437
treatment planning with, 438
in interventional sonography, pediatric, 1943,
1943t
parathyroid adenomas and accuracy of, 748, 748f
Computed tomography (CT) (Continued)
pediatric chest, sonography compared to, 1709,
1710f–1711f
for percutaneous needle biopsies, 599
three-dimensional, in skeletal dysplasia
evaluation, 1384–1385
Concentric hypertrophy, 1294–1295
Conceptual age, deinition of, 1443–1444
ConirmMDx test, 396
Congenital adrenal hyperplasia (CAH)
adrenal rests in, 832–833, 833f, 1824, 1900–1901
pediatric, 1822–1824, 1824f, 1900–1901
Congenital anomalies of kidney and urinary tract
(CAKUT), 1336
Congenital bilateral absence of the vas deferens
(CBAVD), 394
Congenital coxa vara, atypical hips and, 1932
Congenital cystic adenomatoid malformation
(CCAM), 1246, 1248t
fetal, hydrops from, 1426
Congenital diaphragmatic hernia (CDH), 1248t,
1258–1264
anomalies associated with, 1263
bilateral, 1262
fetal lung size and, 1244
FETO for, 1264
let-sided, 1258–1259, 1260f
morbidity and mortality from, 1264, 1264t
prognosis of, 1261–1262, 1262b
right-sided, 1259, 1261f
survival predictors in, 1262, 1262b
in utero therapy for, 1264
Congenital heart block, fetal, 1297, 1297f
hydrops from, 1425
Congenital heart defects, thickened NT in,
1095–1097, 1096f
Congenital heart disease (CHD)
chromosomal anomalies in, 1270
extracardiac malformations in, 1270
fetal arrhythmia and, 1270–1273
hydrops and, 1270
IVF and, 1270–1273
MCDA twins and, 1270–1273
risk factors associated with, 1270,
1271t–1272t
recurrence, in ofspring, 1273t
recurrence, in siblings, 1273t
Congenital high airway obstruction (CHAOS),
1248t, 1253–1255, 1254f
hydrops from, 1426
Congenital hypothyroidism, 694
pediatric ovarian cysts and, 1875
Congenital infantile myoibromatosis, 1664,
1665f
Congenital lobar emphysema, 1246
Congenital lobar overinlation (CLO), 1246,
1251–1252, 1253f
Congenital malformations, obstetric sonography
and, 1041
Congenital myopathy, atypical hips and, 1932
Congenital nephrotic syndrome, CKD and,
1796–1798
Congenital pulmonary airway malformation
(CPAM)
classiication of, 1248
diferential diagnosis of, 1248t
fetal, 1246–1252
hydrops development and, 1248–1249, 1426,
1427f
pediatric, 1715–1716, 1717f
pleuropulmonary blastoma diferentiated from,
1252–1253
sonographic diagnosis of, 1248, 1249f
volume ratio of, 1248, 1250
Congestive heart failure
gallbladder wall thickening and, 199f
neonatal/infant, 1566
Conglomerate masses, Crohn disease and, 269
Conjoined tendon insuiciency
direct inguinal hernia and, 479–481, 483f–484f
sports hernia and, 485–486, 489f
Conjoined twins, 1115–1116
complications with, 1129–1130, 1130f
Conn syndrome, adrenal adenomas in, 419
Connatal cysts, 1566
Connective tissue, dense ibrous, homogeneous
plaque and, 920–921
Conradi-Hünermann syndrome, 1399
Constrictive amniotic bands, 1182–1183
Continuous ambulatory peritoneal dialysis, 521
Continuous wave (CW) devices, 8
Continuous wave Doppler, 24, 25f
Continuous wave probes, with duplex pulsed
Doppler, 939
Continuous wave ultrasound, 36
Contraceptive devices, intrauterine, 529, 552–554,
553f
Contraceptives, oral, hepatic adenomas and, 1746
Contrast, speckle efect on, 13–15, 14f
Contrast agents, 41–42. See also Blood pool
contrast agents
acoustic cavitation and, 43, 44b
avoidance of, in obstetric sonography, 1038
blood pool, 55–56
disruption-replenishment imaging and, 66–67,
67f
echo enhancing, 57f
harmonic imaging with, 58–64
in hydrosonovaginography, 1870–1871, 1871f
intermittent harmonic power Doppler imaging
and, 66, 66f
intermittent imaging with, 64–67, 66f
intravenous Doppler, 1749–1750
intravenous ultrasound, 1746
microbubbles as, 53–54, 54f
behavior of, incident pressure and, 56–58, 57t
disruption of, 64–67, 66f
FNH characterization with, 106, 106f, 108t,
109f
future of technology for, 68–69, 69f–70f
HCC characterization with, 106, 106f
hemangioma characterization with, 106,
106f–107f, 108t
inertial cavitation and, 67–68
lesional enhancement with, 105, 106f–107f,
109f
liver mass characterization with, 105–106,
106f–107f, 108t, 109f–110f
MI and, 58, 58b, 105
need for, 56–58, 57f
regulation of, 68
safety of, 67–68
in musculoskeletal interventions, 898
nonlinear echoes and, 58–64
amplitude and phase modulation imaging
and, 64, 65f
harmonic B-mode imaging and, 60
harmonic spectral and power Doppler and,
60–61, 60f–62f
plane-wave contrast imaging and, 64
pulse inversion Doppler imaging and, 63–64
pulse inversion imaging and, 62–63, 62f–63f
temporal maximum intensity projection
imaging and, 64, 65f
tissue harmonic imaging and, 61–62
perluorocarbons in, 56
for liver mass detection, 107, 111f
requirements for, 54–56
Volume I pp 1–1014 • Volume II pp 1015–1968